Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.151 $0.151 Wednesday, 19th Apr 2023 CLVS stock ended at $0.151. During the day the stock fluctuated 0% from a day low at $0.151 to a day high of $0.151.
90 days $0.120 $0.168
52 weeks $0.0471 $3.25

Historical Clovis Oncology prices

Date Open High Low Close Volume
Apr 01, 2016 $19.02 $19.55 $18.51 $19.37 1 589 099
Mar 31, 2016 $19.27 $19.79 $18.85 $19.20 788 456
Mar 30, 2016 $19.97 $20.99 $18.96 $19.50 669 986
Mar 29, 2016 $18.59 $19.86 $17.76 $19.84 1 195 000
Mar 28, 2016 $19.21 $19.44 $18.42 $18.58 654 600
Mar 24, 2016 $18.45 $19.50 $17.87 $19.03 667 300
Mar 23, 2016 $20.50 $21.19 $18.58 $18.62 856 500
Mar 22, 2016 $19.52 $20.70 $19.52 $20.56 518 000
Mar 21, 2016 $19.27 $20.39 $19.11 $19.76 700 200
Mar 18, 2016 $18.61 $19.50 $18.16 $19.44 1 074 300
Mar 17, 2016 $18.95 $19.00 $17.75 $18.47 673 800
Mar 16, 2016 $18.90 $19.62 $18.39 $18.92 808 100
Mar 15, 2016 $20.24 $20.43 $18.53 $18.92 844 000
Mar 14, 2016 $19.55 $20.61 $19.55 $20.28 512 100
Mar 11, 2016 $19.28 $19.72 $18.88 $19.68 697 400
Mar 10, 2016 $19.87 $20.30 $18.52 $18.96 763 700
Mar 09, 2016 $20.80 $21.03 $19.51 $19.77 680 100
Mar 08, 2016 $22.43 $22.86 $20.38 $20.61 857 000
Mar 07, 2016 $21.52 $22.85 $21.26 $22.51 754 400
Mar 04, 2016 $21.58 $22.85 $20.84 $21.58 1 142 100
Mar 03, 2016 $21.07 $21.95 $20.83 $21.48 1 170 100
Mar 02, 2016 $19.36 $21.53 $19.06 $20.94 1 876 100
Mar 01, 2016 $18.85 $19.40 $18.27 $19.37 906 300
Feb 29, 2016 $19.81 $19.83 $18.51 $18.62 954 100
Feb 26, 2016 $16.79 $19.95 $16.79 $19.70 1 694 100
Click to get the best stock tips daily for free!

About Clovis Oncology

Clovis Oncology Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, as well as for metastatic castration-resistant prostate cancer. In Europe, the... CLVS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT